OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
Shatha Rouf Moustafa, Khalid F. Al-Rawi, Drozdstoy Stoyanov, et al.
Diagnostics (2020) Vol. 10, Iss. 9, pp. 633-633
Open Access | Times Cited: 21

Showing 21 citing articles:

G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63

The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis
Manuel Morrens, C. Overloop, Violette Coppens, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 8, pp. 3237-3246
Open Access | Times Cited: 53

In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.
Abbas F. Almulla, Khalid F. Al-Rawi, Michaël Maes, et al.
Journal of Affective Disorders (2021) Vol. 287, pp. 316-326
Closed Access | Times Cited: 35

Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia
N. А. Shnayder, Aiperi K. Khasanova, Anna Strelnik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11324-11324
Open Access | Times Cited: 24

Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19

A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina
Rana Fadhil Mousa, Hasan Najah Smesam, Hasan Abbas Qazmooz, et al.
CNS Spectrums (2021) Vol. 27, Iss. 6, pp. 676-690
Closed Access | Times Cited: 25

Sex differences in the association of treatment-resistant schizophrenia and serum interleukin-6 levels
Jingqi He, Yisen Wei, Jinguang Li, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8

Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates
Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim, Amer Fadhil Alhaideri, et al.
Metabolic Brain Disease (2020) Vol. 36, Iss. 1, pp. 169-183
Closed Access | Times Cited: 23

Increased ACE2, sRAGE, and Immune Activation, but Lowered Calcium and Magnesium in COVID-19
Hussein Kadhem Al‐Hakeim, Hawraa Kadhem Al-Jassas, Gerwyn Morris, et al.
Recent Advances in Inflammation & Allergy Drug Discovery (2022) Vol. 16, Iss. 1, pp. 32-43
Open Access | Times Cited: 14

Pathway Phenotypes Underpinning Depression, Anxiety, and Chronic Fatigue Symptoms Due to Acute Rheumatoid Arthritis: A Precision Nomothetic Psychiatry Analysis
Hasan Najah Smesam, Hasan Abbas Qazmooz, Sinan Qayes Khayoon, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 476-476
Open Access | Times Cited: 11

Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug
Georgi Panov
Diagnostics (2022) Vol. 12, Iss. 4, pp. 803-803
Open Access | Times Cited: 10

Biomarkers of treatment-resistant schizophrenia: A systematic review
Claudia Pisanu, Giovanni Severino, Alessandra Minelli, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104059-104059
Open Access | Times Cited: 1

In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy
Hussein Kadhem Al‐Hakeim, Rana Fadhil Mousa, Arafat Hussein Al-Dujaili, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 939-955
Closed Access | Times Cited: 10

Hyperexpression of Proinflammatory Cytokines in Blood as a Biomarker of Systemic Inflammatory Response in Schizophrenia: Scoping Review
N. А. Shnayder, G. V. Rusanova, R. F. Nasyrova
Personalized Psychiatry and Neurology (2024) Vol. 4, Iss. 2, pp. 13-24
Open Access

Pharmacological Targets and Mechanisms of Action of Antipsychotic Substances in the Context of the Neurochemical Theory of the Pathogenesis of Schizophrenia
Konstantin Y. Kalitin, А. А. Спасов, Olga Y. Mukha, et al.
Neuroscience and Behavioral Physiology (2022) Vol. 52, Iss. 1, pp. 108-123
Closed Access

Page 1

Scroll to top